真
发表于 2025-3-27 00:56:09
,General Remarks – Allgemeine Hinweise,the commercial aspects of the technology and the requirements attached to the funding mechanisms for clinical development. Early choices about delivery modality and target therapy (indication) have important consequences for the development process. An understanding of the forces that currently driv
craven
发表于 2025-3-27 04:34:09
http://reply.papertrans.cn/29/2831/283051/283051_32.png
杠杆
发表于 2025-3-27 08:44:02
2210-7371 n emphasis on the physiology of the BBB and the principles and concepts for drug delivery across the BBB and distribution within the brain. It contains methods descriptions for studying drug delivery, routes an978-1-4939-4366-1978-1-4614-9105-7Series ISSN 2210-7371 Series E-ISSN 2210-738X
Ibd810
发表于 2025-3-27 11:49:38
http://reply.papertrans.cn/29/2831/283051/283051_34.png
connoisseur
发表于 2025-3-27 17:37:00
Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Rele
或者发神韵
发表于 2025-3-27 21:49:33
http://reply.papertrans.cn/29/2831/283051/283051_36.png
痴呆
发表于 2025-3-27 21:59:42
PKPD Aspects of Brain Drug Delivery in a Translational Perspective
原告
发表于 2025-3-28 03:23:59
Integrated Approach to Optimizing CNS Penetration in Drug Discovery: From the Old to the New Paradig
使厌恶
发表于 2025-3-28 09:15:40
Blood–Brain Barrier (BBB) Pharmacoproteomics: A New Research Field Opened Up by Quantitative Targetes differences, in vitro/in vivo differences, age-related differences, and normal/disease differences, and these need to be understood in order to guide rational drug discovery and development. To address this issue, we have developed an absolute quantification method of protein expression, called qu
adequate-intake
发表于 2025-3-28 13:48:14
http://reply.papertrans.cn/29/2831/283051/283051_40.png